Skip to content
Screener

Quest Diagnostics DGX Q4 2024 Annual earnings

Reported January 30, 2025 · Before market open

Revenue$2.6BBeat by $42.5M
EPS$2.23Beat by $0.04
Revenue estimate$2.6B
EPS estimate$2.19

Next report

Oct 20, 2026 (in 2 months)
Revenue estimate$3.0B
EPS estimate$2.85

Financials

Q4 2024

Income statement

See full
Revenue$2.6B+14.6%
Gross profit$858.0M+16.6%
Operating income$361.0M+35.2%
Net income$222.0M+15.6%
EPS (diluted)$1.95+14.7%

Balance sheet

See full
Cash & equivalents$549.0M-20.0%
Total debt$6.9B+29.1%
Total equity$6.8B+7.5%
Total assets$16.2B+15.2%

Cash flow

See full
Operating cash flow$464.0M-12.0%
CapEx$123.0M+70.8%
Free cash flow$341.0M-25.1%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$16.84B+8.6%
Enterprise value$23.23B+15.0%
P/E19.3×+1.2×
P/S1.7×0.0×

Profitability

See full
Gross margin32.9%-0.1pp
Operating margin13.6%0.0pp
Net margin8.8%-0.4pp
FCF margin9.2%-0.1pp

Returns & leverage

See full
Return on equity13.3%-0.7pp
Debt / equity1×+0.2×
Current ratio1.1×-0.2×

Segments

By segment

See full
DIS business$2.6B+15.1%
All other operating segments$65.0M-3.0%

FAQ

When did Quest Diagnostics report Q4 2024 earnings?
Quest Diagnostics (DGX) reported Q4 2024 earnings on January 30, 2025 before market open.
What were Quest Diagnostics's Q4 2024 revenue and EPS?
Quest Diagnostics reported revenue of $2.6B and eps of $2.23 for Q4 2024.
Did Quest Diagnostics beat estimates in Q4 2024?
Revenue beat the consensus estimate of $2.6B by $42.5M. EPS beat the consensus estimate of $2.19 by $0.04.
Where can I find Quest Diagnostics's Q4 2024 SEC filings?
You can read the 8-K earnings release (0001022079-25-000008) and the 10-K periodic report (0001022079-25-000044) directly on SEC EDGAR. The filing index links above go to sec.gov.